Skip to content
Disclosery

72 Investment Holdings, LLC

Follow

13F filer, CIK 1832749, STAMFORD, CT

72 Investment Holdings, LLC reported $67,947,772 across 5 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000902664-25-005031

Period
2025-09-30
Reported value
$67.9M
Holdings
5
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
TURNSTONE BIOLOGICS CORPexited-549,980-$197K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0000902664-25-005031, largest first. % of portfolio is the value over $67,947,772, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LENZLENZ THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,017,751 shares; 2024Q4: 1,017,751 shares; 2025Q1: 1,017,751 shares; 2025Q2: 1,017,751 shares; 2025Q3: 1,017,751 shares 1,017,751$47.4M69.77%0Timeline
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 276,831 shares; 2024Q4: 276,831 shares; 2025Q1: 276,831 shares; 2025Q2: 276,831 shares; 2025Q3: 276,831 shares 276,831$13.3M19.51%0Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 65,933 shares; 2024Q4: 65,933 shares; 2025Q1: 65,933 shares; 2025Q2: 65,933 shares; 2025Q3: 65,933 shares 65,933$3.49M5.14%0Timeline
ANROALTO NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 667,778 shares; 2024Q4: 667,778 shares; 2025Q1: 667,778 shares; 2025Q2: 667,778 shares; 2025Q3: 667,778 shares 667,778$2.68M3.95%0Timeline
CRBUCARIBOU BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 474,067 shares; 2024Q4: 474,067 shares; 2025Q1: 474,067 shares; 2025Q2: 474,067 shares; 2025Q3: 474,067 shares 474,067$1.1M1.63%0Timeline

Sold out in Q3 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
TURNSTONE BIOLOGICS CORPTURNSTONE BIOLOGICS CORP549,980$197Kshares

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000902664-25-005031 base2025-11-14acceptance time not in the bulk data set